Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Mair Therapeutics
Mair Therapeutics develops small-molecule therapeutics aimed at treating motor symptoms of Parkinson's disease. The company focuses on discovering and optimizing an ion channel activator through…
Mair Therapeutics
Mair Therapeutics develops small-molecule therapeutics aimed at treating motor symptoms of Parkinson's disease. The company focuses on discovering and optimizing an ion channel activator through…
TL;DR
What they do: Preclinical small-molecule program modulating TMEM175 (lysosomal ion channel) to restore lysosomal function in Parkinson's disease.
Stage: Pre-Seed (round closed 2025-02-13)
Investors: Torrey Pines Investment; OostNL
Founded / HQ: Founded 2024; Nijmegen, Netherlands
Company Overview
Problem Domain
Parkinson's disease and neurodegenerative disease driven by lysosomal dysfunction and protein aggregation.
Founded
2024
Industry
Biotechnology
Tech Stack
Funding Track Record
Pre-seed financing announced at company launch; amount not disclosed.
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
500+
New This Week